Education
About Us
Working with TipRanks
Follow Us
Haemonetics (HAE)
:HAE
HAE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$58.80 - $97.97
Previous CloseN/A
Volume53.78K
Average Volume (3M)1.25M
Market Cap
$3.38B
Enterprise Value$4.83B
Total Cash (Recent Filing)$320.85M
Total Debt (Recent Filing)$1.22B
Price to Earnings (P/E)27.0
Beta0.95
Next Earnings
May 13, 2025EPS Estimate
1.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.54
Shares Outstanding50,237,465
10 Day Avg. Volume980,842
30 Day Avg. Volume1,248,324
Financial Highlights & Ratios
PEG Ratio10.61
Price to Book (P/B)N/A
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)19.30
P/FCF Ratio24.00
Enterprise Value/Market Cap1.43
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.99
Enterprise Value/Ebitda18.37
Forecast
1Y Price Target
$97.29Price Target Upside41.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
---
Haemonetics News
PremiumCompany Announcements
Haemonetics Announces Key Executive Leadership Changes---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe full-year adjusted operating margin guidance was raised at the midpoint, indicating a positive outlook for profitability.
Market ShareManagement remains committed to Plasma longer-term, expecting to take material share over the coming quarters and years.
Bears Say
Sales PerformancePlasma growth was below expectations, raising concerns about the current demand and market dynamics.
---
Ownership Overview
1.18% Insiders
49.55% Mutual Funds
0.21% Other Institutional Investors
23.60% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HAE FAQ
What was Haemonetics’s price range in the past 12 months?
Haemonetics lowest stock price was $58.80 and its highest was $97.97 in the past 12 months.
What is Haemonetics’s market cap?
Haemonetics’s market cap is $3.38B.
When is Haemonetics’s upcoming earnings report date?
Haemonetics’s upcoming earnings report date is May 13, 2025 which is in 65 days.
How were Haemonetics’s earnings last quarter?
Haemonetics released its earnings results on Feb 06, 2025. The company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.174 by $0.016.
Is Haemonetics overvalued?
According to Wall Street analysts Haemonetics’s price is currently Undervalued.
Does Haemonetics pay dividends?
Haemonetics does not currently pay dividends.
What is Haemonetics’s EPS estimate?
Haemonetics’s EPS estimate is 1.22.
How many shares outstanding does Haemonetics have?
Haemonetics has 50,237,465 shares outstanding.
What happened to Haemonetics’s price movement after its last earnings report?
Haemonetics reported an EPS of $1.19 in its last earnings report, beating expectations of $1.174. Following the earnings report the stock price went down -11.581%.
Which hedge fund is a major shareholder of Haemonetics?
Currently, no hedge funds are holding shares in HAE
---
Haemonetics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$97.29 (41.62% Upside)
$97.29 (41.62% Upside)
Blogger Sentiment
Bullish
HAE Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 41.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.63%
12-Months-Change
Fundamentals
Return on Equity
14.06%
Trailing 12-Months
Asset Growth
15.04%
Trailing 12-Months
Company Description
Haemonetics
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.
---
HAE Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong growth in the hospital and interventional technologies segments offset by declines in plasma revenue and challenges in China. The company's ability to secure new long-term agreements and record operating margins are positive signs, but the issues with cash flow and certain product lines indicate areas needing improvement.Read More>---
HAE Stock 12 Month Forecast
Average Price Target
$97.29
▲(41.62% Upside)
Technical Analysis
Baxter International
―
Boston Scientific
―
Edwards Lifesciences
―
Hologic
―
Zimmer Biomet Holdings
―
Best Analysts Covering HAE
1 Year
1 Year Success Rate
28/49 ratings generated profit
1 Year Average Return
+6.70%
reiterated a buy rating last month
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +6.70% per trade.
---